ArsenalBio
ArsenalBio engineers T-cell therapies using CRISPR and synthetic biology for cancer treatment.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $325M
About
ArsenalBio engineers T-cell therapies using CRISPR and synthetic biology for cancer treatment.
Cell TherapyOncologyCRISPR
Funding History
1Total raised:$325M
Series C$325M